These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3230648)

  • 21. [Statistical analysis on the question of normal values and physiological variability of serum creatine phosphokinase].
    Feraudi M; Harm K; Schmidt H
    Enzymol Biol Clin (Basel); 1968; 9(5):338-54. PubMed ID: 5303439
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of prednisolone on serum creatine phosphokinase.
    Gupta RC; Gupta U; Garg JP
    Indian J Physiol Pharmacol; 1984; 28(3):243-4. PubMed ID: 6519770
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum cytidine deaminase as a measure of disease activity in rheumatoid arthritis and systemic lupus erythematosus.
    Skeith KJ; Wefuan J; Oswald R; Davis P
    J Rheumatol; 1993 Aug; 20(8):1309-15. PubMed ID: 8230010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The behaviour of creatine phosphokinase in serum after the intramuscular injection of a Tetracyclin preparation (author's transl)].
    Kark B; Bocchi M
    Med Klin; 1975 Aug; 70(34):1341-4. PubMed ID: 1160797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum creatine phosphokinase activity in acute myocardial infarction.
    Basu DP; Chatterjee MK; Ray BP; Maity AK
    Indian Heart J; 1976 Jan; 28(1):24-8. PubMed ID: 992674
    [No Abstract]   [Full Text] [Related]  

  • 26. Low serum creatine phosphokinase values in patients with acute viral hepatitis.
    Rotenberg Z; Weinberger I; Fuchs J; Davidson E; Erdberg A; Sperling O; Agmon J
    Am J Gastroenterol; 1984 Apr; 79(4):276-9. PubMed ID: 6711530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypothyroidism with leading myopathy in a patient suffering from systemic lupus erythematosus and Hashimoto's thyroiditis].
    Judex A; Hartung W; Schölmerich J; Fleck M
    Med Klin (Munich); 2008 Oct; 103(10):731-5. PubMed ID: 18936898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of serum creatine phosphokinase and myokinase activity in psoriatic patients].
    Kipping D
    Z Haut Geschlechtskr; 1969 Jan; 44(2):37-40. PubMed ID: 5360166
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum creatine phosphokinase activity in patients with trichinosis.
    Kedrowa S
    Pol Med J; 1968; 7(6):1338-43. PubMed ID: 5719282
    [No Abstract]   [Full Text] [Related]  

  • 30. [Behavior of serum CPK (creatine phosphokinase) and aldolase levels in psychiatric patients].
    Tropeano G; Del Vecchio M; Amati A; Cocorullo M; Kemali D
    Acta Neurol (Napoli); 1972; 27(4):386-94. PubMed ID: 5085163
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the activity of selected lysosomal exoglycosidases in patients with systemic lupus erythematosus.
    Olczyk K; Drózdz M; Kucharz E; Piwowarczyk B; Kardaszewicz E; Harbut-Gryłka A
    Med Interne; 1984; 22(3):221-5. PubMed ID: 6436958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes of creatine phosphokinase and creatine phosphokinase isoenzyme in primary hypothyroidism before and after the treatment with thyroid hormone].
    Valente O; Muniz JR; Maciel RM; Feder D; Gebara MB
    Rev Paul Med; 1988; 106(3):126-30. PubMed ID: 3251342
    [No Abstract]   [Full Text] [Related]  

  • 33. Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide.
    Hrycek A; Pochopień-Kenig G; Scieszka J
    Autoimmunity; 2007 May; 40(3):217-22. PubMed ID: 17453721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value and significance of changes of serum aldolase and creatine phosphokinase in muscular diseases].
    Corridori F; Lazzaroni M; Lombardi B
    Riv Neurobiol; 1968; 14(4):573-89. PubMed ID: 5738409
    [No Abstract]   [Full Text] [Related]  

  • 35. DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features.
    Martinez-Valle F; Balada E; Ordi-Ros J; Bujan-Rivas S; Sellas-Fernandez A; Vilardell-Tarres M
    Lupus; 2009 Apr; 18(5):418-23. PubMed ID: 19318394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creatine phosphokinase of the blood serum in muscular disorders.
    Sercl M; Kovarík J; Tichý K; Kyral V; Lichý J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1973; 16(3):129-45. PubMed ID: 4531711
    [No Abstract]   [Full Text] [Related]  

  • 37. The normal range for serum creatine phosphokinase.
    McCormick D
    Ir J Med Sci; 1976 Mar; 145(3):86-91. PubMed ID: 1262191
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on serum transaminases and creatine-phosphokinase in tetanus.
    Barua AR; Ghosh BP
    J Indian Med Assoc; 1967 Oct; 49(8):376-80. PubMed ID: 5668339
    [No Abstract]   [Full Text] [Related]  

  • 39. [Activity of creatine phosphokinase (CPK) in the blood serum after coronarography].
    Forkiewicz M; Zelechowska K; Pieńkowska-Vogel M
    Kardiol Pol; 1979; 22(6):627-31. PubMed ID: 529665
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oxygen intermediates and lysosomal enzymes generated by stimulated neutrophils from the patients with systemic lupus erythematosus, Behçet's disease and other disease groups (author's transl)].
    Niwa Y; Ishimoto K; Miyake S; Tsutsui I; Tsutsui D; Yokoyama M
    Nihon Naika Gakkai Zasshi; 1981 Sep; 70(9):1236-48. PubMed ID: 7320606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.